QSAR study of Akt/protein kinase B (PKB) inhibitors using support vector machine

被引:24
作者
Dong, Xiaowu [1 ]
Jiang, Chaoyi [1 ]
Hu, Haiyun [1 ]
Yan, Jingying [1 ]
Chen, Jing [1 ]
Hu, Yongzhou [1 ]
机构
[1] Zhejiang Univ, Coll Pharmaceut Sci, ZJU ENS Joint Lab Med Chem, Hangzhou 310058, Zhejiang, Peoples R China
关键词
Akt/protein kinase B (PKB) inhibitors; Support vector machine (SVM); QSAR; Support vector regression (SVR); Support vector classification (SVC); B/AKT INHIBITORS; DISCOVERY; CANCER; SAR; POTENT; PKB/AKT;
D O I
10.1016/j.ejmech.2009.04.050
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A three-class support vector classification (SVC) model with high prediction accuracy for the training, test and overall data sets (95.2%, 88.6% and 93.1%, respectively) was developed based on the molecular descriptors of 148 Akt/protein kinase B (PKB) inhibitors. Then, support vector regression (SVR) method was applied to set up a more accurate model with good correlation coefficient (r(2)) for the training, test and overall data sets (0.882, 0.762 and 0.840, respectively). Enrichment factors (EF) and receiver operating curves (ROC) studies of database screening were also performed either using the SVR model alone or assisted with the SVC model, the results of which demonstrated that the established models could be useful and reliable tools in identifying structurally diverse compounds with Akt inhibitory activity. (C) 2009 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:4090 / 4097
页数:8
相关论文
共 23 条
[1]   Comparison of support vector machine and artificial neural network systems for drug/nondrug classification [J].
Byvatov, E ;
Fechner, U ;
Sadowski, J ;
Schneider, G .
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 2003, 43 (06) :1882-1889
[2]   LIBSVM: A Library for Support Vector Machines [J].
Chang, Chih-Chung ;
Lin, Chih-Jen .
ACM TRANSACTIONS ON INTELLIGENT SYSTEMS AND TECHNOLOGY, 2011, 2 (03)
[3]   Amplification of AKT2 in human pancreatic cancer cells and inhibition of ATK2 expression and tumorigenicity by antisense RNA [J].
Cheng, JQ ;
Ruggeri, B ;
Klein, WM ;
Sonoda, G ;
Altomare, DA ;
Watson, DK ;
Testa, JR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (08) :3636-3641
[4]   Identification of SVM-based classification model, synthesis and evaluation of prenylated flavonoids as vasorelaxant agents [J].
Dong, Xiaowu ;
Liu, Yujie ;
Yan, Jingying ;
Jiang, Chaoyi ;
Chen, Jing ;
Liu, Tao ;
Hu, Yongzhou .
BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (17) :8151-8160
[5]   Imatinib as a paradigm of targeted therapies [J].
Druker, BJ .
ADVANCES IN CANCER RESEARCH, VOL 91, 2004, 91 :1-+
[6]   Computational methods in developing quantitative structure-activity relationships (QSAR):: A review [J].
Dudek, AZ ;
Arodz, T ;
Gálvez, J .
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2006, 9 (03) :213-228
[7]   How the parts organize in the whole? A top-down view of molecular descriptors and properties for QSAR and drug design [J].
Estrada, Ernesto .
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2008, 8 (03) :213-221
[8]   Synthesis and biological evaluation of 5-arylamino-6-chloro-1H-indazole-4,7-diones as inhibitors of protein kinase B/Akt [J].
Ko, Jong Hee ;
Yeon, Seung Woo ;
Ryu, Jung Su ;
Kim, Tae-Yong ;
Song, Eun-Ha ;
You, Hea-Jung ;
Park, Rae-Eun ;
Ryu, Chung-Kyu .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (23) :6001-6005
[9]   Tyrosine kinases as targets for cancer therapy [J].
Krause, DS ;
Van Etten, RA .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (02) :172-187
[10]   Synthesis and structure-activity relationship of 3,4′-bispyridinylethylenes:: Discovery of a potent 3-isoquinolinylpyridine inhibitor of protein kinase B (PKB/Akt) for the treatment of cancer [J].
Li, Q ;
Woods, KW ;
Thomas, S ;
Zhu, GD ;
Packard, G ;
Fisher, J ;
Li, TM ;
Gong, JC ;
Dinges, J ;
Song, XH ;
Abrams, J ;
Luo, Y ;
Johnson, EF ;
Shi, Y ;
Liu, XS ;
Klinghofer, V ;
Jong, RD ;
Oltersdorf, T ;
Stoll, VS ;
Jakob, CG ;
Rosenberg, SH ;
Giranda, VL .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (07) :2000-2007